BOSTON, Aug. 25, 2011 /PRNewswire/ -- CBI, a division of Advanstar Communications, is pleased to announce that Dr. Ken Kaitin, Director of the Tufts Center for the Study of Drug Development and Research Professor at Tufts University School of Medicine, is the keynote speaker at their Pharma/Bio Forum on Preclinical Development. The conference is being held September 26-27, 2011 at the Hyatt Harborside in Boston, MA. Dr. Kaitin will review today’s research and development landscape and discuss how companies are restructuring to maximize efficiency and boost productivity.
Key success factors for many leading pharmaceutical companies include: alliances and partnerships, understanding the challenges of academic-industry relationships and leveraging translational science. Dr. Kaitin will share insight on the changing environment for preclinical development and new models of innovation. Learn more about Dr. Kaitin’s keynote presentation here.
The recently announced Pfizer innovation center in Boston is just one example of how pharma plans to increase R&D efficiency and lower expenses by teaming up with local hospitals and academic research institutions for innovative drug discovery and translational R&D. Conference presentations designed specifically for those leading innovation in preclinical development include: Best methods for selecting and contracting with a CRO, understand oversight, management and quality challenges with global outsourcing, how to effectively partner with academic institutions, In-licensing and out-licensing - what both sides need to know.
For more information, please call 800-817-8601 or to view the entire agenda please visit http://www.cbinet.com/preclinical or review the agenda. To apply for a press pass, please contact Lauren Donoghue: lauren.donoghue@cbinet.com.
Event Sponsors include Toxikon and MPI Research.
About CBI
A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.
This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.
SOURCE CBI
